Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 21 -30 of 1008 Show results per page	View Search Criteria \| Help With Results

Last Modified: 10/1/1991


21.		Phase II/III Randomized Comparison of VP-16/AMSA vs VP-16/AMSA/AZC in Children with Refractory ANLL (Summary Last Modified 10/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				21 and under				NCI				POG-8820 POG-8820

Last Modified: 3/1/1990


22.		Phase III Treatment of Residual or Unresectable Carcinoma of the Rectum or Rectosigmoid or Localized Pelvic Recurrence Following Resection of Primary Colorectal Cancer: External Beam Radiotherapy plus 5-FU/Leucovorin with Intraoperative Electron Boost vs External Beam Photon Boost (Summary Last Modified 03/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				RTOG-8820 RTOG-88-20

Last Modified: 9/9/2005


23.		Phase II/III Study of Various Schedules of 5-FU Alone and with Modulation by CF or PALA in Patients with Disseminated Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				any age				NCI				SWOG-8905 SWOG-8905

Last Modified: 7/10/2007 First Published: 12/22/2005


24.		Phase II/III Randomized Study of Oxaliplatin, Leucovorin Calcium, and Fluorouracil With Versus Without Maintenance Leucovorin Calcium and Fluorouracil in Patients With Inoperable Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 to 80				Other, Pharmaceutical / Industry				GERCOR-OPTIMOX2 GERCOR-OPTIMOX2-2003, GERCOR-OPTIMOX2-C02-2, EU-20566, SANOFI-GERCOR-OPTIMOX2, NCT00274872


25.		Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				20 to 75				Pharmaceutical / Industry				01023010 / TOP-003 NCT00284258


26.		A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care, Treatment				Closed				18 and over				Pharmaceutical / Industry				20040122 NCT00393822

Last Modified: 2/8/2008


27.		Phase III Randomized Study of Incorporating IFF into Neoadjuvant and Adjuvant DOX/CDDP/MTX Chemotherapy and of MTP-PE During and After Maintenance Chemotherapy in Newly Diagnosed, Resectable Osteogenic Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				not over 30				NCI				CCG-7921 POG-9351, INT-0133

Last Modified: 6/6/2008 First Published: 2/1/1994


28.		Phase III Randomized Study of Three Different Regimens Containing Fluorouracil in Patients With Stage II or III Rectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				over 18				NCI				SWOG-9304 CAN-NCIC-CO11, CLB-9491, E-S9304, NCCTG-934751, RTOG-9403, CLB-C9491, INT-0144, NCT00002551, CO11

Last Modified: 8/1/1994


29.		Phase III Study of Adjuvant Chemotherapy with VCR/MTX Alternating with DOX vs VCR/MTX Alone in Patients with Osteosarcoma (Summary Last Modified 08/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 40								MRC-BO01 EU-94011

Last Modified: 5/8/2007


30.		Phase III Randomized Study of Immediate vs Delayed 5-FU/CF for Asymptomatic Advanced Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				adult under 80								CAN-NCIC-CO10 NCCTG-JCO10, NCCTG-JCO.10, NCI-V94-0463, NCT00002570, CO10, JCO10

Select All on One Page


					< Previous 1 2 3 4 5 6 Next >

| | | | | | | |

A Service of the National Cancer Institute